Behavioral screening for neuroactive drugs in zebrafish
โ Scribed by Jason Rihel; Alexander F. Schier
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2012
- Tongue
- English
- Weight
- 872 KB
- Volume
- 72
- Category
- Article
- ISSN
- 1932-8451
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The larval zebrafish has emerged as a vertebrate model system amenable to small molecule screens for probing diverse biological pathways. Two largeโscale small molecule screens examined the effects of thousands of drugs on larval zebrafish sleep/wake and photomotor response behaviors. Both screens identified hundreds of molecules that altered zebrafish behavior in distinct ways. The behavioral profiles induced by these small molecules enabled the clustering of compounds according to shared phenotypes. This approach identified regulators of sleep/wake behavior and revealed the biological targets for poorly characterized compounds. Behavioral screening for neuroactive small molecules in zebrafish is an attractive complement to in vitro screening efforts, because the complex interactions in the vertebrate brain can only be revealed in vivo. ยฉ 2011 Wiley Periodicals, Inc. Develop Neurobiol 72: 373โ385, 2012
๐ SIMILAR VOLUMES
## Use of Computer-Aided Screening for Detection of Motility Mutants in Zebrafish Embryos T he zebrafish (Danio rerio) is an exquisite vertebrate model system for the study of developmental mechanisms. The unraveling of these developmental processes at the molecular level will allow design of new
## Abstract An in situ hybridization expression screen using a signal sequence trap system has been conducted in zebrafish to isolate cDNAs that encode secreted proteins. Random clones (secreted expressed sequence tags; sESTs) were sequenced from zebrafish embryonic (18โ24 hr postfertilization) and
A screening method for the detection of drugs in haemolysed whole blood has been evaluated. Methanolic extracts of 300 forensic blood samples known to be positive or negative for drugs were analysed with EMIT d.a.u. assay kits for amphetamine, cannabinoids, opiates and benzodiazepines (the latter to